The Binding Mode of Fusion Inhibitor T20 onto HIV-1 gp41 and Relevant T20-Resistant Mechanisms Explored by Computational Study

Publisher： Bentham Science Publishers

E-ISSN： 1873-4251|10|2|182-194

ISSN： 1570-162X

Source： Current HIV Research, Vol.10, Iss.2, 2012-03, pp. : 182-194

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Relative Dominance of Env-gp41-Specific Cytotoxic T Lymphocytes Responses in HIV-1 Advanced Infection

By  

Current HIV Research, Vol. 6, Iss. 3, 2008-05 ,pp. : 239-245

Bentham Science Publishers

Access to resources Recommend Favorite

Influence of subcutaneous injection site on the steady-state pharmacokinetics of enfuvirtide (T-20) in HIV-1-infected patients

By Lalezari J.P.   Patel I.H.   Zhang X.   Dorr A.   Hawker N.   Siddique Z.   Kolis S.J.   Kinchelow T.  

Journal of Clinical Virology, Vol. 28, Iss. 2, 2003-10 ,pp. : 217-222

Elsevier

Access to resources Recommend Favorite

Progress Towards the Development of a HIV-1 gp41-Directed Vaccine

By  

Current HIV Research, Vol. 2, Iss. 2, 2004-01 ,pp. : 193-204

Bentham Science Publishers

Access to resources Recommend Favorite

HIV gp120 is an Aberrant Chemoattractant for Blood Resting CD4 T Cells

By  

Current HIV Research, Vol. 10, Iss. 8, 2012-01 ,pp. : 636-642

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Anti-HIV Agents Targeting Dynamic Supramolecular Mechanism: Entry and Fusion Inhibitors Based on CXCR4/CCR5 Antagonists and gp41-C34-Remodeling Peptides

By  

Current HIV Research, Vol. 3, Iss. 4, 2005-10 ,pp. : 289-301

Bentham Science Publishers

Access to resources Recommend Favorite